% | $
Quotes you view appear here for quick access.

Trius Therapeutics, AŞ Message Board

  • kris_kade kris_kade Jul 14, 2013 9:03 AM Flag

    No secondary, partnership will..

    will fund with attractive terms brining TED into market especially in Europe..expect announcements by end of this year. We will see the same valuation of OPTR if not more prior to FDA approval which is $15 for roughly 48 million OS